Bioequivalence Study Of Gabapentin Between Tablet And Liquid Formulation And The Food Effect Study Of Liquid Formulation
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
Primary objective for this study is to demonstrate bioequivalence between Japanese commercial
tablet and Japanese commercial image liquid formulation. Secondary objective for this study
is to estimate the food effect for Japanese commercial image liquid formulation.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.